Loading...
Loading...
Duncan-Williams, which
raised its PT on shares of Forest Laboratories Inc.
FRX, is providing some color on the stock.
“In a recent SEC filing Forest disclosed that the Icahn parties held 7.20% of the outstanding common stock (fourth largest shareholder behind Wellington, Vanguard, and BlackRock),” Duncan-Williams writes. “We are hopeful that Mr. Icahn's involvement could result in initiatives such as bigger accretive deals using a levered balance sheet, divestiture of non-core assets accompanied by increased operational efficiencies, or cash returns to shareholders. We think that Icahn's move is timely given the potential opportunity to install a new CEO from outside the company.”
Forest Laboratories closed Wednesday at $39.98.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in